NCT01600482View on ClinicalTrials.gov

Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)

NACompletedINTERVENTIONAL

Enrollment

241

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Cardiac DiseaseCoronary Artery Disease

Interventions

DEVICE

CELT ACD

The CELT ACD will be used to achieve hemostasis of the common femoral artery in patients on anticoagulation who are undergoing a percutaneous intervention procedure using a 6F procedural sheath.

Trial Locations (5)

10021

New York Presbyterian Hospital, New York

10117

Charite Campus Mitte, Berlin

08103

Cooper University Hospital, Camden

41464 Neuss

Städtische Kliniken Neuss - Lukaskrankenhaus - GmbH, Preußenstr. 84,41464 Neuss

Unknown

Galway University Hosptial, Galway

All Listed Sponsors

lead

Vasorum Ltd

INDUSTRY

NCT01600482 - Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice) | Biotech Hunter | Biotech Hunter